Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Unknown 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 84 Ovarian Neoplasms 35 Breast Neoplasms 32 Lung Neoplasms 28 Uterine Cervical Neoplasms 18 Triple Negative Breast Neoplasms 15 Fallopian Tube Neoplasms 15 Carcinoma, Ovarian Epithelial 15 Small Cell Lung Carcinoma 13 Squamous Cell Carcinoma of Head and Neck 10 Neuroblastoma 10 Esophageal Neoplasms 10 Esophageal Squamous Cell Carcinoma 8 Central Nervous System Neoplasms 8 Recurrence 7 Head and Neck Neoplasms 6 Endometrial Neoplasms 6 Retinoblastoma 5 Neoplasm Metastasis 5 Brain Neoplasms 5 Adenocarcinoma of Lung 5 Neoplasms 4 Melanoma 4 Carcinoma, Squamous Cell 4 Testicular Neoplasms 3 Oligodendroglioma 3 Medulloblastoma 3 Lymphoma, Large B-Cell, Diffuse 3 Hodgkin Disease 3 Glioblastoma 3

Interventions

130-nm albumin-bound paclitaxel 2 selinexor 1 pembrolizumab 1 isophosphamide mustard 1 epacadostat 1 Sunitinib 1 Ramucirumab 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Leucovorin 1 Histocompatibility Testing 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Epirubicin 1 Cyclophosphamide 1 Cisplatin 1 Chemoradiotherapy 1 Carboplatin 1 68Ga-pentixafor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Thymoma × Carboplatin × Clear all

NCT03921671 2024-05-29

RELEVENT

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Neoplasm Metastasis, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡